21062983|telomerase inhibitor|C1816553|start=4|end=24|PHYS
21062983|cancer stem cells|C1956422|start=45|end=62|ANAT
21062983|breast|C0006141^C1268990|start=66|end=72|ANAT
21062983|pancreatic cancer|C0346647^C2984259^C0235974|start=77|end=94|DISO^CONC
21062983|cell lines|C0007600|start=95|end=105|ANAT
21062983|cancer stem cells|C1956422|start=107|end=124|ANAT
21062983|rare|C0522498^C1514917^C0521114|start=135|end=139|GENE^CONC
21062983|resistant cancer|C0677936|start=145|end=161|DISO
21062983|cell|C1704653^C1136359^C1269647^C0007634^C1948049^C1861886|start=162|end=166|GENE^OBJC^DEVI^ANAT^CONC
21062983|proposed|C1553874^C1578820|start=175|end=183|CONC
21062983|maintenance|C0024501|start=210|end=221|ACTI
21062983|recurrence|C1458156^C0034897^C2825055|start=226|end=236|DISO^PHEN
21062983|cancer|C0006826^C1547140^C1306459^C2707253|start=240|end=246|DISO^OCCU^PHYS
21062983|metastasis|C2939420^C0027627|start=251|end=261|DISO
21062983|active|C1553875^C1561510^C1706449^C1561511^C1561512^C1547419^C1561513^C1561507^C1561508^C1561509^C0205177^C2347179|start=292|end=298|PROC^CONC
21062983|bulk|C0012173|start=307|end=311|OBJC
21062983|tumor cell|C0431085^C0597032|start=312|end=322|ANAT
21062983|populations|C0032659|start=331|end=342|CONC
21062983|limited|C0439801^C3542948|start=356|end=363|CONC
21062983|expression|C0185117^C0017262^C2911684|start=364|end=374|PROC^PHYS^CONC
21062983|normal|C1553402^C2698497^C1550457^C1553406^C1550469^C0205307^C1551394^C1704701^C1553399^C1553386|start=378|end=384|CONC
21062983|tissues|C0040300|start=385|end=392|ANAT
21062983|inhibition|C0021467^C3463820^C0021469|start=400|end=410|PHYS^ACTI
21062983|viable|C0443348|start=448|end=454|CONC
21062983|approach|C0449445|start=455|end=463|CONC
21062983|controlling|C2239193^C2587213|start=467|end=478|PHEN^CONC
21062983|cancer|C0006826^C1547140^C1306459^C2707253|start=479|end=485|DISO^OCCU^PHYS
21062983|growth|C2911660^C0220844^C0018270^C1621966|start=486|end=492|PHYS^ACTI
21062983|studies|C0947630|start=508|end=515|PROC
21062983|currently|C0521116|start=523|end=532|CONC
21062983|phase ii clinical trials|C0282460|start=536|end=560|PROC
21062983|study|C0947630^C2603343^C0557651^C0008972^C1705923^C1880229|start=570|end=575|PROC^OBJC^CONC
21062983|investigated|C1292732|start=580|end=592|CONC
21062983|effects|C1280500|start=597|end=604|CONC
21062983|telomerase inhibitor|C1816553|start=639|end=659|PHYS
21062983|bulk|C0012173|start=673|end=677|OBJC
21062983|cancer cells|C0334227|start=678|end=690|ANAT
21062983|breast|C0006141^C1268990|start=715|end=721|ANAT
21062983|pancreatic cancer|C0346647^C2984259^C0235974|start=726|end=743|DISO^CONC
21062983|cell lines|C0007600|start=744|end=754|ANAT
21062983|treated with|C0332293^C1522326|start=760|end=772|PROC^CONC
21062983|in vitro|C1533691^C2827718^C0021135|start=784|end=792|CONC
21062983|telomerase activity|C1148756|start=794|end=813|PHYS
21062983|bulk|C0012173|start=821|end=825|OBJC
21062983|tumor cells|C0431085|start=826|end=837|ANAT
21062983|inhibited|C0311403|start=866|end=875|CONC
21062983|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=902|end=911|PROC^CONC
21062983|reduced|C0392756|start=912|end=919|CONC
21062983|fractions|C1264633|start=928|end=937|CONC
21062983|present|C0150312^C0449450|start=938|end=945|CONC
21062983|breast|C0006141^C1268990|start=953|end=959|ANAT
21062983|pancreatic|C0030274|start=964|end=974|ANAT
21062983|cell lines|C0007600|start=975|end=985|ANAT
21062983|in vitro|C1533691^C2827718^C0021135|start=987|end=995|CONC
21062983|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=996|end=1005|PROC^CONC
21062983|control|C1547100^C0243148^C3274648^C2587213^C1882979^C1550141|start=1031|end=1038|OBJC^CONC
21062983|reduced|C0392756|start=1062|end=1069|CONC
21062983|proliferation|C0334094^C1514485|start=1074|end=1087|DISO^CONC
21062983|self|C1551994^C0036588^C3244295|start=1092|end=1096|CONC
21062983|potential|C3245505|start=1105|end=1114|CONC
21062983|mcf7|C0596890|start=1118|end=1122|ANAT
21062983|cell death|C0007587|start=1152|end=1162|PHYS
21062983|4 weeks|C1442465|start=1170|end=1177|CONC
21062983|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=1181|end=1190|PROC^CONC
21062983|in vitro|C1533691^C2827718^C0021135|start=1192|end=1200|CONC
21062983|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=1201|end=1210|PROC^CONC
21062983|cells|C3282337^C0007634|start=1220|end=1225|ANAT
21062983|reduced|C0392756|start=1233|end=1240|CONC
21062983|tumor|C0027651^C1578706|start=1241|end=1246|DISO^CONC
21062983|engraftment|C0301944|start=1247|end=1258|PHYS
21062983|nude|C1425014|start=1262|end=1266|GENE
21062983|mice|C1413131^C1417166|start=1267|end=1271|GENE
21062983|concomitant|C0521115|start=1273|end=1284|CONC
21062983|reduction|C0301630^C0392756^C0441610|start=1292|end=1301|PROC^PHEN^CONC
21062983|levels|C0441889|start=1313|end=1319|CONC
21062983|telomerase activity|C1148756|start=1341|end=1360|PHYS
21062983|expression|C0185117^C0017262^C2911684|start=1361|end=1371|PROC^PHYS^CONC
21062983|levels|C0441889|start=1372|end=1378|CONC
21062983|telomere|C0085187|start=1382|end=1390|ANAT
21062983|length|C1444754^C1706316|start=1391|end=1397|PROC^CONC
21062983|bulk|C0012173|start=1410|end=1414|OBJC
21062983|tumor cells|C0431085|start=1415|end=1426|ANAT
21062983|cell lines|C0007600|start=1436|end=1446|ANAT
21062983|increased sensitivity|C1881189^C2346484|start=1474|end=1495|PHEN
21062983|mechanism of action|C1524059^C0031327|start=1532|end=1551|PHYS^CONC
21062983|independent of|C0332291|start=1552|end=1566|CONC
21062983|telomere shortening|C1515263|start=1567|end=1586|DISO
21062983|effects|C1280500|start=1595|end=1602|CONC
21062983|suggest|C1705535|start=1656|end=1663|CONC
21062983|mediated|C0086597|start=1680|end=1688|ACTI
21062983|depletion|C0333668|start=1689|end=1698|CONC
21062983|may|C3812381|start=1707|end=1710|CONC
21062983|alternative|C1523987|start=1720|end=1731|CONC
21062983|mechanism|C1706376^C0441712|start=1732|end=1741|OBJC^CONC
21062983|inhibition|C0021467^C3463820^C0021469|start=1762|end=1772|PHYS^ACTI
21062983|may|C3812381|start=1773|end=1776|CONC
21062983|cancer therapy|C0920425|start=1794|end=1808|PROC
